Selected article for: "effective response and immune system"

Author: Roncati, Luca; Vadalà, Maria; Corazzari, Veronica; Palmieri, Beniamino
Title: COVID-19 vaccine and boosted immunity: nothing ad interim to do?
  • Cord-id: hboc3xcz
  • Document date: 2020_10_9
  • ID: hboc3xcz
    Snippet: SUMMARY Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 (Th1) immune response, tha
    Document: SUMMARY Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 (Th1) immune response, thanks to a subcutaneous vaccine containing lysates of Corynebacterium parvum (synonym for Propionibacterium acnes), a Gram-positive bacterium able to evoke a strong Th1 response.

    Search related documents:
    Co phrase search for related documents
    • activity number and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute respiratory and additional trial: 1, 2, 3, 4, 5
    • acute respiratory syndrome and additional trial: 1, 2, 3, 4, 5